Log in to your Inderes Free account to see all free content on this page.
Bonesupport
360
SEK
+4.05 %
BONEX
NASDAQ Stockholm
Medical Equipment & Services
Health Care
10 following
+4.05%
+9.09%
+29.87%
+40.19%
+91.29%
+119.91%
+793.3%
+1,004.29%
+1,025%
www.bonesupport.com/en-eu/investors
Bone Support is active in medical technology. The company develops and commercializes injectable bioceramic bone graft substitutes that are transformed into the patient's bone and have the ability to release drugs. The company's bone graft substitutes are based on the technology platform Cerament. At present, the company conducts ongoing clinical studies. The company has sales in Europe and North America and is headquartered in Lund, Sweden.
Revenue
591.08M
EBIT %
2.36 %
P/E
95.49
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BONEX
Daily low / high price
346.2 / 361
SEK
Market cap
24.04B SEK
Turnover
43.06M SEK
Volume
121K
Latest videos
Financial calendar
Annual report
25.02.2025
Interim report
24.04.2025
Interim report
15.07.2025
Interim report
23.10.2025
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
HealthCap | 9.9 % | 10.0 % |
Swedbank Robur Fonder | 9.0 % | 9.1 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Announced Insider Trading
Redeye: BONESUPPORT Q3 - Surprising on US sales and EBIT
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio